DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) - LUMOS PHARMA INC ownership

LUMOS PHARMA INC's ticker is LUMO and the CUSIP is 55028X109. A total of 47 filers reported holding LUMOS PHARMA INC in Q1 2020. The put-call ratio across all filers is 5.03 and the average weighting 0.0%.

Quarter-by-quarter ownership
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) ownership history of LUMOS PHARMA INC
ValueSharesWeighting
Q2 2021$331,000
-92.4%
33,117
-91.1%
0.01%
-93.5%
Q1 2021$4,365,000
-86.9%
373,117
-60.1%
0.09%
-86.1%
Q4 2020$33,435,000
+158.4%
936,2910.0%0.66%
+109.8%
Q3 2020$12,940,000
-16.2%
936,291
+0.0%
0.32%
-30.0%
Q2 2020$15,437,000
+94.0%
936,1690.0%0.45%
+77.9%
Q1 2020$7,957,000936,1690.25%
Other shareholders
LUMOS PHARMA INC shareholders Q1 2020
NameSharesValueWeighting ↓
Minerva Advisors LLC 34,015$321,0000.21%
Lion Point Capital, LP 51,205$481,0000.11%
Wealth Advisors of Iowa, LLC 11,699$110,0000.06%
NEA Management Company, LLC 167,608$1,575,0000.04%
Paladin Advisory Group, LLC 4,382$40,0000.03%
Marquette Asset Management, LLC 13,315$125,0000.03%
Blackstone Inc. 468,145$4,401,0000.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 47,643$450,0000.01%
Jefferies Group LLC 120,651$1,134,1190.01%
Renaissance Technologies 271,712$2,554,0000.00%
View complete list of LUMOS PHARMA INC shareholders